Updated U.S. Public Health Service Guidelines for the ...

agement of HIV exposures that included considerations for postexposure prophylaxis (PEP) (3–5). Since publication of the 1998 HIV exposure guidelines (5), several new antiretroviral agents have been approved by the Food and Drug Administration (FDA), and more information is available about the use and safety of HIV PEP ( 6–11). In addition,

  Prophylaxis, Antiretroviral, Postexposure, For postexposure prophylaxis